PloS one · 2013
Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zech Michael, Nübling Georg, Castrop Florian, Jochim Angela, Schulte Eva C, Mollenhauer Brit, Lichtner Peter, Peters Annette, Gieger Christian, Marquardt Thorsten, Vanier Marie T, Latour Philippe, Klünemann Hans, Trenkwalder Claudia, Diehl-Schmid Janine, Perneczky Robert, Meitinger Thomas, Oexle Konrad, Haslinger Bernhard, Lorenzl Stefan, Winkelmann Juliane
Аннотация
Niemann-Pick type C (NPC) disease is a rare autosomal-recessively inherited lysosomal storage disorder caused by mutations in NPC1 (95%) or NPC2. Given the highly variable phenotype, diagnosis is challenging and particularly late-onset forms with predominantly neuropsychiatric presentations are likely underdiagnosed. Pathophysiologically, genetic alterations compromising the endosomal/lysosomal system are linked with age-related neurodegenerative disorders. We sought to examine a possible association of rare sequence variants in NPC1 and NPC2 with Parkinson's disease (PD), frontotemporal lobar degeneration (FTLD) and progressive supranuclear palsy (PSP), and to genetically determine the proportion of potentially misdiagnosed NPC patients in these neurodegenerative conditions. By means of high-resolution melting, we screened the coding regions of NPC1 and NPC2 for rare genetic variation in a homogenous German sample of patients clinically diagnosed with PD (n = 563), FTLD (n = 133) and PSP (n = 94), and 846 population-based controls. The frequencies of rare sequence variants in NPC1/2 did not differ significantly between patients and controls. Disease-associated NPC1/2 mutations were found in six PD patients (1.1%) and seven control subjects (0.8%), but not in FTLD or PSP. All rare variation was detected in the heterozygous state and no compound heterozygotes were observed. Our data do not support the hypothesis that rare NPC1/2 variants confer susceptibility for PD, FTLD, or PSP in the German population. Misdiagnosed NPC patients were not present in our samples. However, further assessment of NPC disease genes in age-related neurodegeneration is warranted.
Предметные рубрики MeSH
Age FactorsAgingCarrier ProteinsFemaleFrontotemporal Lobar DegenerationGenetic Association StudiesGenetic VariationGlycoproteinsHumansIntracellular Signaling Peptides and ProteinsMaleMembrane GlycoproteinsNeurodegenerative DiseasesNiemann-Pick C1 ProteinNiemann-Pick DiseasesParkinson DiseaseSupranuclear Palsy, ProgressiveVesicular Transport Proteins